QPS Study Shows Estetrol Promising for Prostate Cancer Treatment
An investigation into the efficacy and safety of Estetrol (E4) for potential use in the treatment of advanced prostate cancer demonstrated decreased testosterone levels along with acceptable safety parameters. These results suggest that E4 may be suitable for standalone or combination treatment with androgen deprivation therapy (ADT). QPS Netherlands performed the Phase II randomized, double-blind, …
QPS Study Shows Estetrol Promising for Prostate Cancer Treatment Read More »